Examples of using Open-label study in English and their translations into Italian
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
During the longer-term, open-label study(CP045) this was 6.0% of 42,227 episodes in 355 patients treated with PecFent during up to 159 days of treatment.
Adverse reactions data in CAPS patients are based on an open-label study of 43 patients with NOMID/CINCA treated with Kineret for up to 5 years,
GW said on 17 June that results after 12 weeks of therapy in the open-label study were"encouraging", with a reduction in seizure frequency of more than 50 percent.
the efficacy, safety, and pharmacokinetics of E/C/F/TAF FDC tablet were evaluated in an open-label study of 50 HIV-1 infected, treatment-naïve adolescents.
total of 2,833 patients, of which four were double-blind placebo- controlled studies and one was an open-label study.
a single group open-label study(Study GS-US-236-0123) n 910;
consistency with Eslicarbazepine acetate pharmacology and data from open-label study phases and post-marketing safety data.
tenofovir alafenamide were evaluated in an open-label study in which 50 HIV-1 infected, treatment-naïve adolescents received emtricitabine
In an open-label study, 24 paediatric patients(n=10, age 1 to≤
Determine the feasibility of conducting, in conjunction with collaborative groups in Europe and/ or the United States, a Multicenter Randomized Open-Label Study to Evaluate the Safety
for 48 weeks. an open-label study in which pre-(n=226) and post-liver transplantation patients(n=241)
patients were given the opportunity to enter an open-label study.
patients were given the opportunity to enter an open-label study. e DAS28-CRP Remission is defined as a DAS28-CRP score< 2.6.
Therefore the studies were performed as open-label studies.
There are limited safety data from open-label studies in children from 1 month to< 16 years of age.
Phase III Clinical Trials Two randomised, open-label studies were conducted to evaluate the efficacy of dasatinib administered once daily compared with dasatinib administered twice daily.
This includes data from two placebo-controlled studies, three open-label studies, three compassionate-use subjects and postmarketing reports.
However, patients completing STRIDE-2 were eligible to enrol in open-label studies STRIDE-2X and STRIDE-3.
refractory multiple myeloma was demonstrated in two open-label studies.
and TRA100773B and two open-label studies REPEAT(TRA108057) and EXTEND(TRA105325)